NorthSea Therapeutics doses first patient in Phase 1 trial of SEFA-1024 in dyslipidemia and further expands its clinical pipeline

 

MercachemSyncom Changes Name to Symeres

 

Pershing Square Holdings, Ltd. Releases Regular Weekly Net Asset Value and Year-To-Date Return As Of 17 November 2020

 

VERMEG launches Colline.Cloud to help small and medium sized firms meet new Uncleared Margin Rules (UMR) deadline

 

Nucleix’s BE Safe @Home Project Brings Bladder Cancer Surveillance to Patients’ Homes During COVID-19 Pandemic and Beyond

 

Agendia and Paige Announce Landmark Strategic Partnership to Revolutionize Treatment Planning in Breast Cancer

 

Damen and Thales to Build the German MKS 180 Frigate of the Future

 

Agendia Presents Robust and Accurate Next Generation Sequencing Results at the Association for Molecular Pathology 2020 Annual Meeting & Expo

 

Agendia to Showcase Robust Clinical Research at SABCS 2020 Emphasizing Need for Diversity of Data to Treat Breast Cancer Patients

 

eFileCabinet to Expand DMS Offerings and Service to European Customers